Accelerate Diagnostics scheduled call to review 2022 third quarter results
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, November 14, 2022, at 4:30 p....
Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, November 14, 2022, at 4:30 p....
The Global Urinary Tract Infection Testing Market size was estimated at USD 471. 23 million in 2021 and expected to reach USD 518. ...
The Business Research Company’s Antimicrobial Susceptibility Testing Global Market Report 2022: Market Size, Trends, And Forecast To 2026
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced the pricing of an underwritten public offering of...
BD (NYSE:BDX) announced that it entered into a worldwide commercial collaboration agreement with Accelerate Diagnostics (Nasdaq:AXDX).